Respirion Pharmaceuticals Pty Ltd specializes in research and product development in King of Prussia, Pennsylvania. Located at 3602 Horizon Drive Suite 160, this company is dedicated to advancing pharmaceutical innovation through comprehensive research methodologies and cutting-edge product development practices. Its presence in the 19406 area underscores its commitment to contributing to the local scientific community and the broader pharmaceutical industry.
The firm focuses on creating new therapeutic solutions by conducting rigorous laboratory testing and formulation processes. By integrating scientific expertise with technological advancements, Respirion Pharmaceuticals strives to develop effective and safe products that address unmet medical needs. Its operations are supported by accessible facilities, including a wheelchair-accessible entrance and parking lot, ensuring a welcoming environment for all collaborators and visitors.
Respirion Pharmaceuticals maintains regular business hours from 8 a.m. to 5 p.m. Monday through Saturday, with closure on Sundays. This schedule facilitates consistent engagement with clients, research partners, and stakeholders, fostering collaboration and knowledge exchange. The company’s strategic location in King of Prussia allows it to tap into a network of industry professionals and academic institutions, enhancing its research capabilities and product innovation potential.
Through a focused approach to pharmaceutical research and product development, Respirion Pharmaceuticals Pty Ltd plays a role in advancing health care solutions in Pennsylvania. Its work emphasizes scientific rigor, practical application, and accessibility, contributing to the ongoing evolution of pharmaceutical technologies and therapies within the region.


































